Safety Follow-up in 350 patients after stem cell therapy

июля 20, 2009

Autologous Stem Cell Transplantation by lumbar puncture: A safety Follow up-in 350 patients

ABSTRACT:

Background

Autologous stem cells show promise in preclinical animal models as a cell transplantation therapy for repair of the injured spinal cord, to supplement neural cells in Parkinson, Multiple Sclerosis, Cerebral Palsy and Stroke patients . The procedure of first choice to implant stem cells is lumbar puncture. This procedure is safe and minimal invasive. This paper summarizes the experiences with autologous stem cell therapy and reports the results of 350 lumbar punctures used to inject autologous stem cells into the intrathecal space.

Methods and Results

A short review of the recent literature looking at the aspect side effects and safety and an oversight of the side effects, reported by post treatment surveillance of patients from XCell-Center Germany. XCell-Center evaluates the side effects of a transplantation with autologous stem cells, using a standard Post Treatment Survey. In this paper, 350 patients with a lumbar puncture as procedure for delivery of the stem cells is reviewed forside effects, using the results of the Post Treatment Surveys. The results of these patients are compared with the side effects after lumbar puncture, reported in literature.

Conclusions

Within XCell-center, The incidence of Post Dural Puncture Headache is estimated as low as 3,7% (13 cases out of 350 patients). There were no reported side effects concerning fever, skin rashes, shock or tachycardia.Therefore, the transplantation of autologous stem cells seems to be safe and the lumbar puncture is a safe and non-invasive procedure to inject the stem cells into the intrathecal space. The Post Treatment Survey is a good quality instrument to monitor the safety of the procedure.

Keywords

Autologous stem cells; lumbar puncture; therapy, safety;

Read the entire follow-up in PDF-format.

Новости
  • Stem cells and tumor risk подробнее…
  • 3 июня, 2010
    Xcell-Центр получает разрешение от ведомства здравоохранения Франции на проведение клинических исследований со стволовыми клетками при хронических заболеваниях спинного мозга. подробнее…
  • 9 февраля, 2010
    Saving Limbs: Autologous Mesenchymal cells for the treatment of patients with critical limb ischemia – an Interim Analysis подробнее…
  • 4 февраля, 2010
    Autologous Stem Cell Transplantation by Lumbar Puncture: A safety Follow-up in 870 Patients подробнее…
  • 2 февраля, 2010
    Parkinson's Treatment Results Available Now! подробнее…
  • 5 января, 2010
    XCell-Center Duesseldorf attains ISO 9001 certification подробнее…
  • 29 декабря, 2009
    XCell-Center Newsletter - December 2009 подробнее…
  • 2 декабря, 2009
    The Prescott Daily Courier features Parkinson's Patient, Aubra Phillips подробнее…
  • 18 ноября, 2009
    Our 2009 Patient Satisfaction Survey Results are in! подробнее…
  • 7 октября, 2009
    XCell-Center Commences Neuro-endoscopic Autologous Stem Cell Treatments in Germany подробнее…
  • 1 октября, 2009
    Autism Patients Show Progress Following Stem Cell Therapy подробнее…
  • TV Link: About XCell-Center подробнее…
  • News archive 2009 подробнее…
  • News archive 2008 подробнее…
  • News archive 2007 подробнее…